1. Home
  2. KELYA vs AVIR Comparison

KELYA vs AVIR Comparison

Compare KELYA & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc.

KELYA

Kelly Services Inc.

HOLD

Current Price

$10.61

Market Cap

324.4M

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$4.09

Market Cap

318.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYA
AVIR
Founded
1946
2012
Country
United States
United States
Employees
N/A
56
Industry
Professional Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.4M
318.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KELYA
AVIR
Price
$10.61
$4.09
Analyst Decision
Buy
Hold
Analyst Count
1
1
Target Price
$16.00
$6.00
AVG Volume (30 Days)
424.7K
520.9K
Earning Date
02-13-2026
03-05-2026
Dividend Yield
2.68%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,392,800,000.00
N/A
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.46
N/A
52 Week Low
$7.98
$2.46
52 Week High
$15.11
$4.34

Technical Indicators

Market Signals
Indicator
KELYA
AVIR
Relative Strength Index (RSI) 61.61 62.12
Support Level $9.84 $3.75
Resistance Level $11.39 $4.31
Average True Range (ATR) 0.39 0.24
MACD 0.08 0.04
Stochastic Oscillator 59.14 76.51

Price Performance

Historical Comparison
KELYA
AVIR

About KELYA Kelly Services Inc.

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: